Dr. Siegel on Study of Induction Chemotherapy and Transoral Surgery in Oropharyngeal Cancer

Robert Siegel, MD
Published: Tuesday, Aug 22, 2017



Robert Siegel, MD, chair, professor of medicine, director, Division of Hematology/Oncology, George Washington University, discusses a study of induction chemotherapy and transoral surgery in patients with oropharyngeal cancer.

In a phase II study, the efficacy of induction chemotherapy and transoral surgery was studied as a definitive treatment for oropharyngeal squamous cell carcinoma.

Through this regimen, Siegel hopes to eliminate the morbidly of radiation therapy, which is the current standard of care for these patients.
 


Robert Siegel, MD, chair, professor of medicine, director, Division of Hematology/Oncology, George Washington University, discusses a study of induction chemotherapy and transoral surgery in patients with oropharyngeal cancer.

In a phase II study, the efficacy of induction chemotherapy and transoral surgery was studied as a definitive treatment for oropharyngeal squamous cell carcinoma.

Through this regimen, Siegel hopes to eliminate the morbidly of radiation therapy, which is the current standard of care for these patients.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Clinical Interchange™: Translating Research to Inform Changing Paradigms: Assessment of Emerging Immuno-Oncology Strategies and Combinations across Lung, Head and Neck, and Bladder CancersOct 31, 20182.0
Community Practice Connections™: Precision Medicine for Community Oncologists: Assessing the Role of Tumor-Testing Technologies in Cancer CareNov 30, 20181.0
Publication Bottom Border
Border Publication
x